MetLife Investment Management’s PureCycle Technologies PCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PCT
SC
AWC
LAMI
RCMU
SC
MetLife Investment Management's PCT Position: Q2 2026 in Review
MetLife Investment Management increased its PureCycle Technologies (PCT) stake by 11% in Q2 2026, buying an estimated $77.8K and bringing the position to 86,116 shares worth $698K. The position accounts for ﹤0.01% of the portfolio, ranked #1728.
MetLife Investment Management first reported a position in PCT in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.06M in Q2 2025. 312 funds tracked by Wall St. Rank hold PCT as of Q2 2026.
- MetLife Investment Management held 86,116 shares of PureCycle Technologies worth $698K as of Q2 2026.
- MetLife Investment Management bought 8,674 PureCycle Technologies shares in Q2 2026, an estimated $77.8K.
- PureCycle Technologies made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1728 holding.
- MetLife Investment Management first reported a position in PureCycle Technologies in Q2 2021 and has held it in 21 quarters since.
- MetLife Investment Management's PureCycle Technologies position peaked at $1.06M in Q2 2025.
- 312 funds tracked by Wall St. Rank held PureCycle Technologies as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.